Common symptoms associated with usage and cessation of anabolic androgenic steroids in men

Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101691. doi: 10.1016/j.beem.2022.101691. Epub 2022 Aug 12.

Abstract

Anabolic-androgenic steroid (AAS) have widespread and growing illicit use as image and performance enhancing drugs (IPED), predominantly in young men. Users trying to stop AAS are prone to distressing withdrawal symptoms which may trigger relapse in use. It is important to develop therapies to support AAS withdrawal. The illicit nature of AAS use has impeded the robust characterisation of its clinical withdrawal syndrome within any single study. Therefore, we conducted a systematic review summarising the available clinical studies describing symptoms associated with non-medically indicated AAS use, and AAS withdrawal. Reported clinical features of AAS withdrawal include headache, fatigue, myalgia, restlessness, insomnia, low mood and libido, anorexia, suicidal ideation, body image dissatisfaction, and steroid cravings; novel therapies for AAS withdrawal would need evaluation against these symptoms.

Keywords: androgenic anabolic steroids; androgens; dependency; men; substance misuse; withdrawal.

Publication types

  • Review
  • Systematic Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anabolic Agents* / adverse effects
  • Androgens / adverse effects
  • Humans
  • Male
  • Performance-Enhancing Substances*
  • Steroids
  • Testosterone Congeners / adverse effects

Substances

  • Anabolic Agents
  • Androgens
  • Performance-Enhancing Substances
  • Steroids
  • Testosterone Congeners